MPG.eBooks - Search Results

Cover Image

61

CADTH Canadian Drug Expert Committee recommendation: Ivabradine hydrochloride (Lancora -- Servier Canada Inc.) : indication: heart failure, NYHA class II to III.

Published 2017

Canadian Agency for Drugs and Technologies in Health

Cover Image

62

CADTH Canadian Drug Expert Committee final recommendation: Sarilumab (Kevzara -- Sanofi Genzyme) : indication: rheumatoid arthritis

Published 2017

Canadian Agency for Drugs and Technologies in Health

Cover Image

63

CADTH Canadian Drug Expert Committee recommendation: Nusinersen (Spinraza -- Biogen Canada Inc.) : indication : treatment of 5q spinal muscular atrophy

Published 2017

Canadian Agency for Drugs and Technologies in Health

Cover Image

64

CDEC final recommendation: Tiotropium bromide (Spiriva respimat -- Boehringer Ingelheim Canada Ltd.) : indication : chronic obstructive pulmonary disease

Published 2015

Canadian Agency for Drugs and Technologies in Health

Cover Image

65

CADTH Canadian Drug Expert Committee recommendation: Ocrelizumab (Ocrevus -- Hoffmann-La Roche Limited) : indication : treatment of adult patients with relapsing-remitting multiple...

Published 2017

Canadian Agency for Drugs and Technologies in Health

Cover Image

66

CADTH Canadian Drug Expert Committee recommendation: AbobotulinumtoxinA (Dysport therapeutic -- Ipsen Biopharmaceuticals Canada Inc.) : indication: for the symptomatic treatment of...

Published 2017

Canadian Agency for Drugs and Technologies in Health

Cover Image

67

CADTH Canadian Drug Expert Committee recommendation: Iron isomaltoside 1000 (Monoferric -- pharmacosmos A/S) : indication: for the treatment of iron deficiency anemia in adult pati...

Published 2020

CADTH

Cover Image

68

CADTH Canadian Drug Expert Committee recommendation: Ixekizumab (Taltz -- Eli Lilly Canada Inc.) : indication: ankylosing spondylitis

Published 2020

CADTH

Cover Image

69

CADTH Canadian Drug Expert Committee recommendation: Belimumab (Benlysta subcutaneous [SC] -- GlaxoSmithKline Inc.) : indication: systemic lupus erythematosus (SLE)

Published 2020

CADTH

Cover Image

70

CADTH Canadian Drug Expert Committee Recommendation: Onabotulinumtoxin A (Botox -- Allergan Inc.) : indication: chronic migraine

Published 2019

CADTH

Cover Image

71

CADTH Canadian Drug Expert Committee recommendation: Eliglustat (Cerdelga -- Sanofi Genzyme) : indication: Type 1 Gaucher disease

Published 2017

Canadian Agency for Drugs and Technologies in Health

Cover Image

72

CADTH Canadian Drug Expert Committee recommendation: Fluocinolone acetonide (Iluvien -- Knight Therapeutics Inc.) : indication : diabetic macular edema

Published 2019

Canadian Agency for Drugs and Technologies in Health

Cover Image

73

CADTH Canadian Drug Expert Committee recommendation: Dolutegravir/Lamivudine (Dovato -- ViiV healthcare ULC) : indication: as a complete regimen for the treatment of human immunode...

Published 2019

CADTH

Cover Image

74

CADTH Canadian Drug Expert Committee recommendation: Fluticasone Propionate (Aermony respiclick -- Teva Canada Innovation) : indication : maintenance treatment of asthma in patient...

Published 2018

CADTH

Cover Image

75

CADTH Canadian Drug Expert Committee recommendation: Glucagon nasal powder (Baqsimi -- Eli Lilly Canada Inc) : indication: for the treatment of severe hypoglycemia (SH) reactions w...

Published 2020

CADTH

Cover Image

76

CADTH Canadian drug expert committee recommendation: Cyclosporine 0.1% (Verkazia -- Santen Canada Inc.) : indication : treatment of severe vernal keratoconjunctivitis in children f...

Published 2019

Canadian Agency for Drugs and Technologies in Health

Cover Image

77

CADTH Canadian Drug Expert Committee recommendation: Cerliponase Alfa (Brineura -- Biomarin Pharmaceutical [Canada] Inc.) : indication : for the treatment of neuronal ceroid lipofu...

Published 2019

CADTH

Cover Image

78

CADTH Canadian Drug Expert Committee recommendation: Efinaconazole (Jublia -- Bausch Health, Canada Inc.) : indication : for the topical treatment of mild to moderate onychomycosis...

Published 2019

CADTH

Cover Image

79

CADTH Canadian Drug Expert Committee recommendation: Risankizumab (Skyrizi -- Abbvie) : indication : adult patients with moderate to severe plaque psoriasis

Published 2019

CADTH

Cover Image

80

CADTH Canadian drug expert committee recommendation: Buprenorphine (Sublocade -- Indivior Canada Ltd.) : indication: opioid use disorder

Published 2019

Canadian Agency for Drugs and Technologies in Health

1
2
3
4
5
6
7
8
9
10
11